ALG1L13P

Across TCGA pan-cancer cohorts, ALG1L13P RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated ALG1L13P data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher ALG1L13P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ALG1L13P expression acts as an unfavorable survival marker, although some lineages such as BRCA and LAML show a favorable association.

THCA, LGG, and KIRC are the cancer types where ALG1L13P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	III,IV	0.631	1.000	.003	71	view →
LGG	DFS	Median	All	0.636	0.834	<.001	54	view →
KIRC	DFS	Quartile	III,IV	0.365	0.614	.004	53	view →
BRCA	OS	Tertile	II,III,IV	0.971	0.933	.001	41	view →
LAML	DFS	Median	All	0.494	0.266	.004	34	view →
ACC	DFS	Tertile	II,III,IV	0.375	0.787	.010	22	view →
UCS	OS	Tertile	II,III,IV	0.243	0.597	.028	20	view →
SKCM	DFS	Tertile	IV	0.943	0.194	.024	14	view →
STAD	DFS	Quartile	IV	0.120	0.740	.005	12	view →
THYM	DFS	Tertile	III,IV	1.000	0.208	.002	12	view →
KIRP	DFS	Median	All	0.495	0.697	.011	11	view →
DLBC	DFS	Quartile	All	0.455	1.000	.029	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

ALG1L13P–THCA (OS)

Open the THCA breakdown →